Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TCRX

TScan Therapeutics, Inc.

CIK 0001783328 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.06
↓ 0.20 (-15.87%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$25.42M
P/E Ratio
-0.20
EPS
-1.00
Dividend Yield
Not covered
52W Position
13%
Beta
1.85

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.26
P/S
2.78
EV/Revenue
-7.66
ROE
-128.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%
$0.83$2.57

Latest Financials

2025-12-31 FY
Revenue
$10.32M
Net Income
-$129.77M
Total Assets
$228.79M
Free Cash Flow
-$139.73M

Recent news